Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD)

Abstract

Purpose

Health outcomes may depend on which treatment is received, whether choice of treatment is given, and whether a received treatment is the preferred therapy. We examined the effects of these key factors on the EuroQol-5D (EQ-5D-3L) in patients with PTSD.

Methods

Two hundred patients aged 18–65 years with PTSD diagnosis enrolled in a doubly randomized preference trial (DRPT) examining treatment, choice of treatment, and treatment-preference effects of prolonged exposure therapy (PE) and pharmacotherapy with sertraline (SER) (clinicaltrials.gov Identifier: NCT00127673). We performed difference-in-difference analysis to estimate the treatment effects of prolonged exposure therapy (PE) as compared to pharmacotherapy with sertraline (SER), receipt of choice versus no-choice of treatment, and receipt of preferred versus non-preferred treatment on health-related quality-of-life (HRQOL) outcome using the EQ-5D-3L completed at baseline and 10-week post-treatment.

Results

The treatment effects of PE on the EQ-5D scores in overall patients and subgroup of patients who preferred PE were 0.150 (p = 0.025) and 0.223 (p < 0.001), respectively. The effects of treatment choice were 0.088 (p = 0.050) and 0.156 (p = 0.043) in overall patients and subgroup of patients received SER, respectively. The effects of treatment preference were 0.101 (p = 0.038) and 0.249 (p = 0.004) in overall patients and subgroup of patients SER, respectively.

Conclusions

Overall, PE is associated with better improved HRQOL, especially in patients who prefer it. Independently, allowing patients to choose their preferred treatment resulted in better HRQOL than either assigning them a treatment or giving them a treatment that is not preferred.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Kilpatrick, D. G., Resnick, H. S., Milanak, M. E., Miller, M. W., Keyes, K. M., & Friedman, M. J. (2013). National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. Journal of Traumatic Stress, 5, 537–547.

    Article  Google Scholar 

  2. 2.

    Eibner, C., Ringel, J. S., Kilmer, B., Pacula, R. L., & Diaz, C. (2008). The cost of post-deployment mental health and cognitive conditions. In T. Tanielian & L. H. Jaycox (Eds.), Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery. Santa Monica: RAND.

    Google Scholar 

  3. 3.

    Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA, 283(14), 1837–1844.

    Article  PubMed  CAS  Google Scholar 

  4. 4.

    Resick, P. A., Nishith, P., Weaver, T. L., Astin, M. C., & Feuer, C. A. (2002). A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. Journal of Consulting and Clinical Psychology, 70(4), 867–879.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Jaeger, J. A., Echiverri, A., Zoellner, L. A., Post, L., & Feeny, N. C. (2009). Factors associated with choice of exposure therapy for PTSD. International Journal of Behavioral and Consultation Therapy, 5(3–4), 294–310.

    PubMed  PubMed Central  Google Scholar 

  6. 6.

    Feeny, N. C., Zoellner, L. A., Mavissakalian, M. R., & Roy-Byrne, P. P. (2009). What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women. Depress Anxiety, 26(8), 724–731.

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Rucker, G. (1989). A two-stage trial design for testing treatment, self-selection and treatment preference effects. Statistics in Medicine, 4, 477–485.

    Article  Google Scholar 

  8. 8.

    Torgerson, D. J., & Sibbald, B. (1998). Understanding controlled trials. What is a patient preference trial? BMJ, 316, 360.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. 9.

    Long, Q., Little, R. J., & Lin, X. H. (2008). Causal inference in hybrid intervention trials involving treatment choice. Journal of the American Statistical Association, 103, 474–484.

    Article  CAS  Google Scholar 

  10. 10.

    Shadish, W. R., Clark, M. H., & Steiner, P. M. (2008). Can nonrandomized experiments yield accurate answers? A randomized experiment comparing random and nonrandom assignments. Journal of the American Statistical Association, 103, 1334–1344.

    Article  CAS  Google Scholar 

  11. 11.

    Marcus, S. M., Stuart, E. A., Wang, P., Shadish, W. R., & Steiner, P. M. (2012). Estimating the causal effect of randomization versus treatment preference in a doubly randomized preference trial. Psychol Methods, 17(2), 244–254.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Mitchell-Jones, N., Farren, J. A., Tobias, A., Bourne, T., & Bottomley, C. (2017). Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: A randomised control trial with patient preference arm. British Medical Journal Open, 7(12), e017566.

    Google Scholar 

  13. 13.

    Hubacher, D., Spector, H., Monteith, C., Chen, P. L., & Hart, C. (2017). Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: A randomized patient preference trial. American Journal of Obstetrics and Gynecology, 216(2), 101–109.

    Article  PubMed  Google Scholar 

  14. 14.

    Elmagied, A. M., Vaughan, L. E., Weaver, A. L., et al. (2016). Fibroid interventions: Reducing symptoms today and tomorrow: Extending generalizability by using a comprehensive cohort design with a randomized controlled trial. American Journal of Obstetrics and Gynecology, 215, 338.e1–338.e18.

    Article  Google Scholar 

  15. 15.

    Howie, F. L., Henshaw, R. C., Naji, S. A., et al. (1997). Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. British Journal of Obstetrics and Gynaecology, 104, 829–833.

    Article  PubMed  CAS  Google Scholar 

  16. 16.

    Henshaw, R. C., Naji, S. A., Russell, I. T., et al. (1994). A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Human Reproduction, 9, 2167–2172.

    Article  PubMed  CAS  Google Scholar 

  17. 17.

    Janevic, M. R., Janz, N. K., Dodge, J. A., Lin, X., Pan, W., Sinco, B. R., & Clark, N. M. (2003). The role of choice in health education intervention trials: a review and case study. Social Science and Medicine, 56(7), 1581–1594.

    Article  PubMed  Google Scholar 

  18. 18.

    Yancy, W. S. Jr., Mayer, S. B., Coffman, C. J., Smith, V. A., Kolotkin, R. L., Geiselman, P. J., McVay, M. A., Oddone, E. Z., & Voils, C. I. (2015). Effect of allowing choice of diet on weight loss: A randomized trial. Annals of Internal Medicine, 162(12), 805–814.

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    He, Y., Gewirtz, A., Lee, S., Morrell, N., & August, G. (2016). A randomized preference trial to inform personalization of a parent training program implemented in community mental health clinics. Translational Behavioral Medicine, 6(1), 73–80.

    Article  PubMed  Google Scholar 

  20. 20.

    Swift, J. K., & Callahan, J. L. (2009). The impact of client treatment preferences on outcome: A meta-analysis. Journal of Clinical Psychology, 65(4), 368–381.

    Article  PubMed  Google Scholar 

  21. 21.

    Swift, J. K., Callahan, J. L., Vollmer, B. (2011). Preferences. Journal of Clinical Psychology, 67, 155–165.

    Article  PubMed  Google Scholar 

  22. 22.

    Freed, M. C., Yeager, D. E., Liu, X., Gore, K. L., Engel, C. C., & Magruder, K. M. (2009). Preference-weighted health status of PTSD among veterans: An outcome for cost-effectiveness analysis using clinical data. Psychiatric Services, 60, 1230–1238.

    Article  PubMed  Google Scholar 

  23. 23.

    Craig, B. M., Pickard, S. A., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67, 93–99.

    Article  PubMed  Google Scholar 

  24. 24.

    Neumann, P. J., Goldie, S. J., & Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587–611.

    Article  PubMed  CAS  Google Scholar 

  25. 25.

    Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43, 203–220.

    Article  PubMed  Google Scholar 

  26. 26.

    Feeny, N. C., & Zoellner, L. A. Talk presented at: 2010 American Psychiatric Association Annual Meeting (Symposium 12: Anxiety Treatment—New Research Findings for the Clinician); May 22, 2010; New Orleans, LA.

  27. 27.

    Youngstrom, E. A., Feeny, N. C., Zoellner, L. A., Mavissakalian, M., & Roy-Byrne, P. Doubly Randomized Preference Trial in PTSD—Prolonged Exposure versus Sertraline (Symposium 5032). Talk presented at: American Psychological Association Annual Convention; August 3, 2013; Honolulu, HI.

  28. 28.

    Le, Q. A., Doctor, J. N., Zoellner, L. A., & Feeny, N. C. (2014). Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): A doubly randomized preference trial. The Journal of Clinical Psychiatry, 75(3), 222–230.

    Article  PubMed  Google Scholar 

  29. 29.

    Kind, P. (2003). Guidelines for value sets in economic and on-economic studies using EQ-5D. In R. Brooks, R. Rabin & F. D. Charro. The measurement and valuation of health status using EQ-5D: A European perspective (pp. 29–42). Amsterdam: Springer.

    Google Scholar 

  30. 30.

    Abadie, A. (2005). Semiparametric difference-in-differences estimators. The Review of Economic Studies, 72, 1–19.

    Article  Google Scholar 

  31. 31.

    Athey, S., & Imbens, G. W. (2006). Identification and inference in nonlinear difference-in-differences models. Econometrica, 74, 431–497.

    Article  Google Scholar 

  32. 32.

    Beard, C., Weisberg, R. B., & Keller, M. B. (2010). Health-related Quality of Life across the anxiety disorders: Findings from a sample of primary care patients. Journal of Anxiety Disorders, 24(6), 559–564.

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Stoll, C., Schelling, G., Goetz, A. E., Kilger, E., Bayer, A., et al. (2000). Health-related quality of life and post-traumatic stress disorder in patients after cardiac surgery and intensive care treatment. The Journal of Thoracic and Cardiovascular Surgery, 120(3), 505–512.

    Article  PubMed  CAS  Google Scholar 

  34. 34.

    Schnurr, P. P., Hayes, A. F., Lunney, C. A., McFall, M., & Uddo, M. (2006). Longitudinal analysis of the relationship between symptoms and quality of life in veterans treated for posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 74(4), 707–713.

    Article  PubMed  Google Scholar 

  35. 35.

    Haagsma, J. A., Polinder, S., Olff, M., Toet, H., Bonsel, G. J., & van Beeck, E. F. (2012). Posttraumatic stress symptoms and health-related quality of life: A two year follow up study of injury treated at the emergency department. BMC Psychiatry, 12, 1.

    Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Kapfhammer, H. P., Rothenhäusler, H. B., Krauseneck, T., Stoll, C., & Schelling, G. (2004). Posttraumatic stress disorder and health-related quality of life in long-term survivors of acute respiratory distress syndrome. American Journal of Psychiatry, 161(1), 45–52.

    Article  PubMed  Google Scholar 

  37. 37.

    Pittman, J. O., Goldsmith, A. A., Lemmer, J. A., Kilmer, M. T., & Baker, D. G. (2012). Post-traumatic stress disorder, depression, and health-related quality of life in OEF/OIF veterans. Quality of Life Research, 21(1), 99–103.

    Article  PubMed  Google Scholar 

  38. 38.

    Mancino, M. J., Pyne, J. M., Tripathi, S., Constans, J., Roca, V., & Freeman, T. (2006). Quality-adjusted health status in veterans with posttraumatic stress disorder. The Journal of Nervous and Mental Disease, 194(11), 877–879.

    Article  PubMed  Google Scholar 

  39. 39.

    Giacco, D., Matanov, A., & Priebe, S. (2013). Symptoms and subjective quality of life in post-traumatic stress disorder: A longitudinal study. PLoS ONE 8(4), e60991.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. 40.

    Johansen, V. A., Wahl, A. K., Eilertsen, D. E., Weisaeth, L., & Hanestad, B. R. (2007). The predictive value of post-traumatic stress disorder symptoms for quality of life: A longitudinal study of physically injured victims of non-domestic violence. Health Qual Life Outcomes, 5, 26.

    Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Le, Q. A., Doctor, J. N., Zoellner, L. A., & Feeny, N. C. (2013). Minimal clinically important differences for the EQ-5D and QWB-SA in post-traumatic stress disorder (PTSD): Results from a Doubly Randomized Preference Trial (DRPT). Health Qual Life Outcomes, 11, 59.

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Zoellner, L. A., Feeny, N. C., Cochran, B., & Pruitt, L. (2003). Treatment choice for PTSD. Behaviour Research and Therapy, 41, 879–886.

    Article  PubMed  Google Scholar 

  43. 43.

    Williams, M., Cahill, S., & Foa, E. Psychotherapy for post-traumatic stress disorder. D. Stein & E. Hollander, B. Rothbaum (Eds.), Textbook of anxiety disorders (2nd edn.) Washington:American Psychiatric Publishing, 2010.

    Google Scholar 

  44. 44.

    Rubin, D. B. (1978). Bayesian inference for causal effects: The role of randomization. Annals of Statistics, 6, 34–58.

    Article  Google Scholar 

Download references

Funding

This research was supported by Grants R01MH066347 and R01MH066348 from the National Institute of Mental Health (“Effectiveness of PTSD Treatment: Prolonged Exposure Therapy vs. Zoloft”).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Quang A. Le.

Ethics declarations

Conflict of interest

The authors declare that they do not have conflicts of interest.

Ethical approval

The study was approved by the Institutional Review Boards (IRB) of the Case Western Reserve University/University Hospital of Cleveland and University of Washington. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 31 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Le, Q.A., Doctor, J.N., Zoellner, L.A. et al. Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD). Qual Life Res 27, 1555–1562 (2018). https://doi.org/10.1007/s11136-018-1833-4

Download citation

Keywords

  • Treatment preference
  • Treatment choice
  • Prolonged exposure therapy
  • Sertraline
  • Posttraumatic stress disorder
  • EQ-5D-3L